TNF and rheumatoid arthritis: Many cytokine inhibitors, including those targeting IL‐1β, IL‐6, and TNF‐α, have been approved for the treatment of inflammatory diseases, such as bone destruction and rheumatoid arthritis (Rao et al., 2013).